Hepatitis C Virus Core Protein Induces Homotolerance and Cross-Tolerance to Toll-Like Receptor Ligands by Activation of Toll-Like Receptor 2

被引:45
作者
Chung, Hobyung [2 ]
Watanabe, Tomohiro [1 ]
Kudo, Masatoshi [2 ]
Chiba, Tsutomu
机构
[1] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan
[2] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan
关键词
NEGATIVE REGULATOR; IMMUNE-RESPONSES; ADAPTER PROTEIN; DENDRITIC CELLS; INFECTION; INDUCTION; LIVER; ANTIGEN; INTERLEUKIN-6; ASSOCIATION;
D O I
10.1086/655812
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Hepatitis C virus (HCV) activates host innate immune responses mediated by retinoic acid inducing gene-I (RIG-I) and Toll-like receptors (TLRs). Although the nonstructural protein 3/4A (NS3/4A) of HCV disrupts interferon responses by inhibiting RIG-I signaling, the effects of TLR activation by HCV-associated proteins on host innate immune responses are poorly understood. Methods. Proinflammatory cytokine responses to various TLR ligands in human antigen-presenting cells (APCs) were examined either with or without prestimulation by HCV core protein. Results. TLR2 activation by the HCV core protein leads to a decrease in interleukin 6 (IL-6) production by human APCs after subsequent stimulation with TLR2 (homotolerance) ligands and TLR4 (cross-tolerance) ligands. This hyporesponsiveness induced by preexposure to the HCV core protein was partially mediated by the negative regulation of nuclear factor-kappa B activation by the induction of IRAK-M. TLR ligand-induced IL-6 production was significantly reduced in peripheral blood monocytes isolated from HCV-infected patients, compared with those of healthy control subjects. Alloantigen presentation by monocytes isolated from HCV-infected patients results in impaired production of interleukin 17 by naive CD4(+) T cells in the presence of TLR ligands. Conclusions. Chronic stimulation of APCs with HCV core protein is associated with hyporesponsiveness in TLR-mediated innate immunity.
引用
收藏
页码:853 / 861
页数:9
相关论文
共 50 条
  • [11] Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
    Guriec, Nathalie
    Bussy, Frederick
    Gouin, Christelle
    Mathiaud, Olivier
    Quero, Benoit
    Le Goff, Matthieu
    Collen, Pi Nyvall
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [12] Toll-Like Receptor 2 or Toll-Like Receptor 4 Deficiency Does Not Modify Lupus in MRLlpr Mice
    Freeley, Simon J.
    Giorgini, Angela
    Tulone, Calogero
    Popat, Reena J.
    Horsfield, Catherine
    Robson, Michael G.
    PLOS ONE, 2013, 8 (09):
  • [13] Toll-like receptor 2 and type 2 diabetes
    Sepehri, Zahra
    Kiani, Zohre
    Nasiri, Ali Akbar
    Kohan, Farhad
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2016, 21
  • [14] Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes
    Grunvogel, Oliver
    Colasanti, Ombretta
    Lee, Ji-Young
    Kloess, Volker
    Belouzard, Sandrine
    Reustle, Anna
    Esser-Nobis, Katharina
    Hesebeck-Brinckmann, Jasper
    Mutz, Pascal
    Hoffmann, Katrin
    Mehrabi, Arianeb
    Koschny, Ronald
    Vondran, Florian W. R.
    Gotthardt, Daniel
    Schnitzler, Paul
    Neumann-Haefelin, Christoph
    Thimme, Robert
    Binder, Marco
    Bartenschlager, Ralf
    Dubuisson, Jean
    Dalpke, Alexander H.
    Lohmann, Volker
    GASTROENTEROLOGY, 2018, 154 (08) : 2237 - +
  • [15] Polymorphisms in vitamin D receptor, toll-like receptor 2 and Toll-Like receptor 4 genes links with Dengue susceptibility
    Singh, Arvind Kumar
    Prakash, Shantanu
    Garg, R. K.
    Jain, Parul
    Kumar, Rashmi
    Jain, Amita
    BIOINFORMATION, 2021, 17 (04) : 506 - 513
  • [16] Role of genetic variants of Vitamin D receptor, Toll-like receptor 2 and Toll-like receptor 4 in extrapulmonary tuberculosis
    Wani, Bilal Ahmad
    Shehjar, Faheem
    Shah, Sonaullah
    Koul, Ajaz
    Yusuf, Adfar
    Farooq, Muzamil
    Mir, Mohmad Iqbal
    Singh, Rajni
    Afroze, Dil
    MICROBIAL PATHOGENESIS, 2021, 156
  • [17] Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection
    Chung, H.
    Watanabe, T.
    Kudo, M.
    Chiba, T.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (10) : E561 - E567
  • [18] Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B
    Akbal, Erdem
    Kocak, Erdem
    Koklu, Seyfettin
    Ergul, Bilal
    Akyurek, Omer
    Yilmaz, Fatma Meric
    VIRAL IMMUNOLOGY, 2017, 30 (04) : 278 - 282
  • [19] Epigenetic Regulation of Tolerance to Toll-Like Receptor Ligands in Alveolar Epithelial Cells
    Neagos, Jacqueline
    Standiford, Theodore J.
    Newstead, Michael W.
    Zeng, Xianying
    Huang, Steven K.
    Ballinger, Megan N.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2015, 53 (06) : 872 - 881
  • [20] TOLL-LIKE RECEPTOR SIGNALING PATHWAYS AND THE EVIDENCE LINKING TOLL-LIKE RECEPTOR SIGNALING TO CARDIAC ISCHEMIA/REPERFUSION INJURY
    Wang, Yue
    Abarbanell, Aaron M.
    Herrmann, Jeremy L.
    Weil, Brent R.
    Poynter, Jeffrey
    Manukyan, Mariuxi C.
    Crisostomo, Paul R.
    Meldrum, Daniel R.
    SHOCK, 2010, 34 (06): : 548 - 557